Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) shares saw strong trading volume on Monday . Approximately 146,631 shares traded hands during trading, an increase of 111% from the previous session’s volume of 69,418 shares.The stock last traded at $6.2910 and had previously closed at $6.34.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings cut Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, July 29th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.
View Our Latest Stock Analysis on NNNN
Anbio Biotechnology Price Performance
About Anbio Biotechnology
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.
Further Reading
- Five stocks we like better than Anbio Biotechnology
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
- Rocket Lab Insiders Are Selling—But Institutions Keep Buying
- 3 European Defense Stocks Raising Guidance While the Sector Lags
Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
